Pau Llacer

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications

Lower-limb compression in AHF and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial.

Lower-limb compression in AHF and predominant tissue congestion: rationale and design of the COMPRESSION-HF trial.

Journal: ESC heart failure
Published: June 25, 2026

Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's reply.

Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's reply.

Journal: European journal of internal medicine
Published: May 17, 2026

Prognostic impact of kidney function in a large contemporary ambulatory heart failure cohort.

Prognostic impact of kidney function in a large contemporary ambulatory heart failure cohort.

Journal: Revista espanola de cardiologia (English ed.)
Published: April 21, 2026

Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study.

Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study.

Journal: International journal of cardiology
Published: April 19, 2026

Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study.

Chronic obstructive pulmonary disease and CA125 levels in ambulatory chronic heart failure: The COPA-HF study.

Journal: International journal of cardiology
Published: April 19, 2026

Prognostic impact of pleural effusion in acute heart failure and its link to diuretic therapy.

Prognostic impact of pleural effusion in acute heart failure and its link to diuretic therapy.

Journal: The American journal of medicine
Published: April 17, 2026

Worsening renal function in acute heart failure: a hemoconcentration-conditioned interpretation with ranges of benefit, safety, and harm.

Worsening renal function in acute heart failure: a hemoconcentration-conditioned interpretation with ranges of benefit, safety, and harm.

Journal: Revista espanola de cardiologia (English ed.)
Published: April 08, 2026

Worsening renal function in acute heart failure: a hemoconcentration-conditioned interpretation with ranges of benefit, safety, and harm.

Worsening renal function in acute heart failure: a hemoconcentration-conditioned interpretation with ranges of benefit, safety, and harm.

Journal: Revista espanola de cardiologia (English ed.)
Published: April 08, 2026

Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI).

Acetazolamide effects on natriuresis and diuresis in acute heart failure treated with furosemide and SGLT2i (SANDI).

Journal: ESC heart failure
Published: January 19, 2026

Acetazolamide Effects on Natriuresis and Diuresis in Acute Heart Failure Treated with Furosemide and SGLT2i (SANDI).

Acetazolamide Effects on Natriuresis and Diuresis in Acute Heart Failure Treated with Furosemide and SGLT2i (SANDI).

Journal: ESC heart failure
Published: January 19, 2026

Serum chloride and the response to hydrochlorothiazide in patients with acute heart failure: a post-hoc analysis from the CLOROTIC trial.

Serum chloride and the response to hydrochlorothiazide in patients with acute heart failure: a post-hoc analysis from the CLOROTIC trial.

Journal: Revista espanola de cardiologia (English ed.)
Published: January 14, 2026

Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectives.

Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectives.

Journal: Revista clinica espanola
Published: December 11, 2025
Showing 1-12 of 95

Last Updated: 09/26/2026